References
- Brant JA, Naples J e, Ruckenstein MJ, et al. Infections of the external ear. In Flint PW, Francis HW, Haunghey BH, Lesperance MM. Cummings otolaryngology: Head and neck surgery. 7th ed. Philadelphia: Elsevier; 2021. p. 2093–2010.
- Rosenfeld RM, Schwartz SR, Cannon CR, et al. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014;150(1 Suppl):S1–S24.
- Chander J. Otomicose por Aspergillus. Aspergillu&Aspergillosis [Internet]. 2009. Feb [cited 2021 sept 05]. Available from: https://www.aspergillus.org.uk/new_treatment/aspergillus-otomycosis/.
- Mofatteh MR, Naseripour YZ, Yousefi M, et al. Comparison of the recovery rate of otomycosis using betadine and clotrimazole topical treatment. Braz J Otorhinolaryngol. 2018;84(4):404–409.
- European Committee on Antimicrobial Susceptibility Testing: Antifungal Agents, Breakpoint tables for interpretation of MICs: Version 9.0 [Internet], valid from 2018. 02-12. Available from: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/AFST/Clinical_breakpoints/Antifungal_breakpoints_v_9.0_180212.pdf.
- Infarmed. Prontuário terapêutico on-line [Internet] [cited 2021. Sept 05] Available from: https://app10.infarmed.pt/prontuario/framepesactivos.php?palavra=fluconazol&x=0&y=0&rb1=0.
- Ho T, Vrabec JT, Yoo D, et al. Otomycosis: Clinical features and treatment implications. Otolaryngol Head Neck Surg. 2006;135(5):787–791.
- Kurnatowski P, Filipiak A. Otomycosis: prevalence, clinical symptoms, therapeutic procedure. Mycoses. 2001;44(11-12):472–479.
- Bonaparte JP, Herasym K, Kilty S. A comparison of Locacorten-Vioform and clotrimazole in otomycosis: a systematic review and one-way meta-analysis. Laryngoscope. 2016;126(6):1411–1419.
- García-Agudo L, Aznar-Marín P, Galán-Sánchez F, et al. Otomycosis due to filamentous fungi. Mycopathologia. 2011;172(4):307–310.
- Mugliston T, O'Donoghue G. Otomycosis – a continuing problem. J Laryngol Otol. 1985;99(4):327–333.
- Nielsen PG. Fungi isolated from chronic external ear disorders mykosen. Mykosen. 1985;28(5):234–237.
- Tasić-Otašević S, Golubović M, Đenić S, et al. Species distribution patterns and epidemiological characteristics of otomycosis in southeastern serbia. J Mycol Med. 2020;30(3):101011.
- Neto MI, Simão MA. Otomicose: uma revisão. Repositório da Universidade de Lisboa [Internet]. 2019. [cited 2021 sept 05]. Available from: http://hdl.handle.net/10451/43294.
- Westby D, O'Connell N, Powell J, et al. The changing nature of paediatric otomycosis in the mid-west of Ireland. J Laryngol Otol. 2020;134(7):592–596.
- Agarwal P, Devi LS. Otomycosis in a rural community attending a tertiary care hospital: assessment of risk factors and identification of fungal and bacterial agents. J Clin Diagn Res. 2017;11(6):DC14–DC18.
- Ali K, Hamed MA, Hassan H, et al. Identification of fungal pathogens in otomycosis and their drug sensivity: our experience. Int Arch Otorhinolaryngol. 2018;22(4):400–403.
- Anwar K, Gohar MS. Otomycosis: clinical features, predisposing factors ant treatment implications. Pak J Med Sci. 2014;30(3):564–567.
- Prasad SC, Kotigadde S, Shekhar M, et al. Primary otomycosis in the indian subcontinent: predisposing factors, microbiology, and classification. Int J Microbiol. 2014;2014:636493.
- Nemati S, Hassanzadeh R, Khajeh Jahromi S, et al. Otomycosis in the North of Iran: common pathogens and resistance to antifungal agents. Eur Arch Otorhinolaryngol. 2014;271(5):953–957.